Annual Report 2023
Division of Population Data Science
Kota Katanoda, Kayo Togawa, Hirokazu Tanaka, Sayo Tanaka, Nguyen The Phuong, Babu Hellen Wairimu, Fuka Falahola Oe Langi, Tshewang Gyeltshen, Hasan Jamil, Kazuaki Arai, Kayo Sone, Chikage Orito, Chinatsu Kojima
Introduction
The Division of Population Data Science develops and analyzes comprehensive cancer statistics information including cancer registry data to contribute to the development and evaluation of evidence-based cancer control.
The Team and What We Do
With the aim to clarify the cancer burden in our society and realize optimal cancer control policies, our research focuses on descriptive epidemiology and policy evaluation by leveraging national and international cancer statistics, geographic information systems (GISs), and other sources of information. More specifically, we describe cancer trends, geographical patterns, prevention, screening, and other phases of the cancer control continuum, and also evaluate cancer control measures using mathematical approaches such as simulation modelling and health economics.
Research Activities
1. Cancer statistics website "Cancer Information Service"
Cancer statistics data and graphical information such as cancer incidence, mortality and survival are provided on the website “Cancer Information Service”, managed by Institute for Cancer Control. Our analysis using cancer statistics information is published as a scientific publication in the Japanese Journal of Clinical Oncology (JJCO) and other academic journals. For the general public, the booklet "Cancer Statistics" is also published annually. This fiscal year, we provided cancer mortality data for 2022 and cancer incidence data for 2019 and published the booklet "Cancer statistics in Japan 2024".
2. Research on cancer statistics and cancer control
Cancer statistics information is analyzed and combined with information on cancer prevention, early detection, diagnosis, treatment, palliative care, and health economics to develop and evaluate cancer control policies. This fiscal year, we examined the effect of COVID-19 pandemic on mortality and the impact of changes in the standard population on vital statistics.
3. Others
Our research activities also cover a variety of analysis on cancer and life-style related diseases prevention, early detection, treatment, etc. In this fiscal year, economic burden of cancer attributable to modifiable risk factors in Japan was examined.
Education
Graduate students were openly recruited in our division under the framework of a joint graduate school in the field of Cancer Statistics and Informatics in collaboration with Osaka University Graduate School of Medicine. Job training opportunities were provided for graduate students at the School of Public Health, St. Luke's International University in the scope of setting up a future joint graduate school program.
Future Prospects
Based on the development and analysis of cancer statistics information, we aim to realize effective and efficient cancer control measures through the cancer control continuum from prevention to treatment and palliative care.
List of papers published in 2023
Journal
1. Momosaka T, Saito J, Otsuki A, Yaguchi-Saito A, Fujimori M, Kuchiba A, Katanoda K, Takaku R, Shimazu T. Associations of individual characteristics and socioeconomic status with heated tobacco product harmfulness perceptions in Japan: A nationwide cross-sectional study (INFORM Study 2020). Journal of epidemiology, 2024
2. Tsuge H, Kawakita D, Taniyama Y, Oze I, Koyanagi YN, Hori M, Nakata K, Sugiyama H, Miyashiro I, Oki I, Nishino Y, Katanoda K, Ito Y, Shibata A, Matsuda T, Iwasaki S, Matsuo K, Ito H. Subsite-specific trends in mid- and long-term survival for head and neck cancer patients in Japan: A population-based study. Cancer science, 115:623-634, 2024
3. Palmer MR, Saito E, Katanoda K, Sakamoto H, Hocking JS, Brotherton JML, Ong JJ. The impact of alternate HPV vaccination and cervical screening strategies in Japan: a cost-effectiveness analysis. The Lancet regional health. Western Pacific, 44:101018, 2024
4. Tanaka H, Katanoda K, Togawa K, Kobayashi Y. Educational inequalities in all-cause and cause-specific mortality in Japan: national census-linked mortality data for 2010-15. International journal of epidemiology, 53:dyae031, 2024
5. Ong SK, Abe SK, Thilagaratnam S, Haruyama R, Pathak R, Jayasekara H, Togawa K, Bhandari AKC, Shankar A, Nessa A, Jugder U, Agustina J, Biglari M, Yusuf A, Tshomo U, Fernando E, Cairo C, Kaung KK, Rath B, Vongdala C, Pradhananga KK, Kim J, Chung YK, Thanh Huong TT, Sangrajran S, Zhang Y, Basu P, Woo YL, Sukumaran B, Hwang WYK. Towards elimination of cervical cancer - human papillomavirus (HPV) vaccination and cervical cancer screening in Asian National Cancer Centers Alliance (ANCCA) member countries. The Lancet regional health. Western Pacific, 39:100860, 2023
6. Saito E, Tanaka S, Abe SK, Hirayabashi M, Ishihara J, Katanoda K, Lin Y, Nagata C, Sawada N, Takachi R, Goto A, Tanaka J, Ueda K, Hori M, Matsuda T, Inoue M. Economic burden of cancer attributable to modifiable risk factors in Japan. Global health & medicine, 5:238-245, 2023
7. Tanaka H, Mackenbach JP, Kobayashi Y. Estimation of Socioeconomic Inequalities in Mortality in Japan Using National Census-linked Longitudinal Mortality Data. Journal of epidemiology, 33:246-255, 2023
8. Tanaka H, Tanaka S, Togawa K, Katanoda K. Practical Implications of the Update to the 2015 Japan Standard Population: Mortality Archive From 1950 to 2020 in Japan. Journal of epidemiology, 33:372-380, 2023
9. Mitsutake S, Takahashi Y, Otsuki A, Umezawa J, Yaguchi-Saito A, Saito J, Fujimori M, Shimazu T. Chronic Diseases and Sociodemographic Characteristics Associated With Online Health Information Seeking and Using Social Networking Sites: Nationally Representative Cross-sectional Survey in Japan. Journal of medical Internet research, 25:e44741, 2023
10. Goto A, Katanoda K. Should We Acknowledge ChatGPT as an Author? Journal of epidemiology, 33:333-334, 2023
11. Minami T, Inoue M, Tabuchi T, Katanoda K. Voluntary suspension of medically-assisted reproduction during the COVID-19 pandemic in Japan: a nationwide internet survey. Human fertility (Cambridge, England), 26:169-181, 2023
12. Charvat H, Fukui K, Matsuda T, Katanoda K, Ito Y. Impact of cancer and other causes of death on mortality of cancer patients: A study based on Japanese population-based registry data. International journal of cancer, 153:1162-1171, 2023
13. Katanoda K, Tanaka H, Tanaka S, Togawa K. Toward Better Utilization of the 2015 Japan Standard Population. Journal of epidemiology, 33:545, 2023
14. Sugiyama T, Yanagisawa-Sugita A, Tanaka H, Ihana-Sugiyama N, Imai K, Ohsugi M, Ueki K, Tamiya N, Kobayashi Y. Different incidences of diabetic retinopathy requiring treatment since diagnosis according to the course of diabetes diagnosis: a retrospective cohort study. Scientific reports, 13:10527, 2023
15. Nakata K, Matsuda T, Hori M, Sugiyama H, Tabuchi K, Miyashiro I, Matsumoto K, Yoneda A, Takita J, Shimizu C, Katanoda K. Cancer incidence and type of treatment hospital among children, adolescents, and young adults in Japan, 2016-2018. Cancer science, 114:3770-3782, 2023
16. Kim J, Leon ME, Schinasi LH, Baldi I, Lebailly P, Freeman LEB, Nordby KC, Ferro G, Monnereau A, Brouwer M, Kjaerheim K, Hofmann JN, Straif K, Kromhout H, Schüz J, Togawa K. Exposure to pesticides and risk of Hodgkin lymphoma in an international consortium of agricultural cohorts (AGRICOH). Cancer causes & control, 34:995-1003, 2023
17. Usui Y, Ito H, Katanoda K, Matsuda T, Maeda Y, Matsuo K. Trends in non-Hodgkin lymphoma mortality rate in Japan and the United States: A population-based study. Cancer science, 114:4073-4080, 2023
18. Tanaka H, Togawa K, Katanoda K. Impact of the COVID-19 pandemic on mortality trends in Japan: a reversal in 2021? A descriptive analysis of national mortality data, 1995-2021. BMJ open, 13:e071785, 2023
19. Palmer M, Katanoda K, Saito E, Acuti Martellucci C, Tanaka S, Ikeda S, Sakamoto H, Machalek D, Brotherton JML, Hocking JS. Corrigendum to "Genotype prevalence and age distribution of human papillomavirus from infection to cervical cancer in Japanese women: A systematic review and meta-analysis" [Vaccine 40(41) (2022) 5971-5996]. Vaccine, 41:6135, 2023
20. Funada S, Yoshioka T, Luo Y, Iwama T, Mori C, Yamada N, Yoshida H, Katanoda K, Furukawa TA. Global Trends in Highly Cited Studies in COVID-19 Research. JAMA network open, 6:e2332802, 2023
21. Nguyen PT, Hori M, Matsuda T, Katanoda K. Cancer Prevalence Projections in Japan and Decomposition Analysis of Changes in Cancer Burden, 2020-2050: A Statistical Modeling Study. Cancer epidemiology, biomarkers & prevention, 32:1756-1770, 2023
22. Boucheron P, Zietsman A, Pontac J, Hansen R, Anderson BO, Togawa K, Macharia PM, Foerster M, Schüz J, Dos-Santos-Silva I, McCormack V. Analysis of the Breast Cancer Journey in Namibia. JAMA network open, 6:e2341402, 2023